Klinikum Ludwigshafen

Ludwigshafen 67063

0 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Diffuse Large B-cell Lymphoma, Heart Failure NYHA Class III and Ambulatory IV, Lymphoma, PONV, Postoperative Nausea and Vomiting

Studies at this site

• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
• Phase IIIb Study of APD421 in Combination as PONV Prophylaxis — Completed
• Phase II Dose-ranging Study of APD421 in PONV — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV) — Completed